首页> 外文期刊>The biochemical journal >Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2
【24h】

Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2

机译:螺旋4中Cys140的鉴定为大鼠平衡硝基苄基硫代肌苷(NBMPR)不敏感的核苷转运蛋白rENT2的底物易位通道中的半面半胱氨酸残基

获取原文

摘要

pThe human and rat equilibrative nucleoside transporter proteins hENT1, rENT1, hENT2 and rENT2 belong to a family of integral membrane proteins with 11 potential transmembrane segments (TMs), and are distinguished functionally by differences in transport of nucleobases and sensitivity to inhibition by nitrobenzylthioinosine (NBMPR) and vasoactive drugs. In the present study, we have produced recombinant hENT1, rENT1, hENT2 and rENT2 in iXenopus/i oocytes and investigated uridine transport following exposure to the impermeant thiol-reactive reagent ip/i-chloromercuriphenyl sulphonate (PCMBS). PCMBS caused reversible inhibition of uridine influx by rENT2, but had no effect on hENT1, hENT2 or rENT1. This difference correlated with the presence in rENT2 of a unique Cys residue (Cyssup140/sup) in the outer half of TM4 that was absent from the other ENTs. Mutation of Cyssup140/sup to Ser produced a functional protein (rENT2/C140S) that was insensitive to inhibition by PCMBS, identifying Cyssup140/sup as the exofacial Cys residue in rENT2 responsible for PCMBS inhibition. Uridine protected wild-type rENT2 against PCMBS inhibition, suggesting that Cyssup140/sup in TM4 lies within or is closely adjacent to the substrate-translocation channel of the transporter. TM4has been shown previously to be within a structural domain (TMs 3?6) responsible for interactions with NBMPR, vasoactive drugs and nucleobases./p
机译:>人类和大鼠平衡核苷转运蛋白hENT1,rENT1,hENT2和rENT2属于具有11个潜在跨膜片段(TMs)的整合膜蛋白家族,其功能在于通过区分核碱基的运输和对被抑制的敏感性硝基苄硫代肌苷(NBMPR)和血管活性药物。在本研究中,我们在非洲爪蟾卵母细胞中产生了重组hENT1,rENT1,hENT2和rENT2,并研究了暴露于不渗透硫醇反应剂 p -氯汞基苯磺酸盐后尿苷的转运(PCMBS)。 PCMBS引起rENT2对尿苷流入的可逆抑制,但对hENT1,hENT2或rENT1没有影响。这种差异与rENT2中TM4外部一半中唯一的Cys残基(Cys 140 )的存在相关,而其他ENTs则不存在。将Cys 140 突变为Ser可产生对PCMBS抑制不敏感的功能蛋白(rENT2 / C140S),从而将Cys 140 识别为负责PCMBS的rENT2的面外Cys残基抑制。尿苷保护野生型rENT2不受PCMBS抑制,提示TM4中的Cys 140 位于转运蛋白的底物转运通道内或紧邻转运蛋白的底物转运通道。以前已证明TM4在结构域内(TMs 3?6),负责与NBMPR,血管活性药物和核碱基的相互作用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号